Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fludrocortisone 100microgram tablets
0603010I0AAACAC
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 92,973 |
|
Fludrocortisone 50microgram tablets
0603010I0AACACA
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 7,365 |
|
Fludrocortisone 50micrograms/5ml oral suspension
0603010I0AABYBY
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 203 |
|
Fludrocortisone 100micrograms/ml oral solution sugar free
0603010I0AACBCB
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 161 |
|
Fludrocortisone 100micrograms/5ml oral suspension
0603010I0AABZBZ
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 117 |
|
Fludrocortisone 250micrograms/5ml oral suspension
0603010I0AAA8A8
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 6 |
|
Fludrocortisone 50microgram capsules
0603010I0AAAJAJ
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 4 |
|
Fludrocortisone 20micrograms/5ml oral suspension
0603010I0AABHBH
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | 1 |
|
Fludrocortisone 10micrograms/5ml oral suspension
0603010I0AAA9A9
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 125micrograms/5ml oral suspension
0603010I0AAA3A3
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 130micrograms/5ml oral suspension
0603010I0AABWBW
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 150microgram capsules
0603010I0AABSBS
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 150micrograms/5ml oral suspension
0603010I0AAA2A2
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 187.5micrograms/5ml oral suspension
0603010I0AABQBQ
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 1mg/5ml oral suspension
0603010I0AABEBE
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 200micrograms/5ml oral suspension
0603010I0AAA6A6
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 25micrograms/5ml oral suspension
0603010I0AAA5A5
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 30microgram capsules
0603010I0AABXBX
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 30micrograms/5ml oral suspension
0603010I0AABVBV
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 400micrograms/5ml oral suspension
0603010I0AABUBU
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 500micrograms/5ml oral suspension
0603010I0AAA4A4
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 600micrograms/5ml oral suspension
0603010I0AABFBF
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 62.5micrograms/5ml oral suspension
0603010I0AABCBC
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 625micrograms/5ml oral suspension
0603010I0AABJBJ
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 750micrograms/5ml oral suspension
0603010I0AABIBI
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.